BEGIN:VCALENDAR
PRODID:-//Columba Systems Ltd//NONSGML CPNG/SpringViewer/ICal Output/3.3-
 M3//EN
VERSION:2.0
CALSCALE:GREGORIAN
METHOD:PUBLISH
BEGIN:VEVENT
DTSTAMP:20131106T081116Z
DTSTART:20131127T130000Z
DTEND:20131127T140000Z
SUMMARY:Reversible and Irreversible Inhibitors of the Cell Cycle-Associat
 ed Kinases CDK2 and Nek2 as Prospective Antitumour Agents
UID:{http://www.columbasystems.com/customers/uom/gpp/eventid/}oev-hn4dia5
 h-e2po2
DESCRIPTION:'''Host:''' Manchester Pharmacy School\n\n'''About the event:
 ''' \n\nBiography:\n\nRoger Griffin is Professor of Medicinal Chemistry 
 and Co-director of Drug Development at Newcastle University's Northern I
 nstitute for Cancer Research (NICR). A graduate in Pharmacy at the Unive
 rsity of Portsmouth in 1981\, he completed a PhD in Medicinal Chemistry 
 at Aston University\, before taking up a lectureship in the Department o
 f Pharmaceutical Sciences in 1985. He moved to Newcastle in 1990\, and w
 as appointed to his current post in 2001. The main focus of Roger Griffi
 n's research is anticancer medicinal chemistry\n
STATUS:TENTATIVE
TRANSP:TRANSPARENT
CLASS:PUBLIC
LOCATION:Lecture theatre 6\, Stopford Building\, Manchester
END:VEVENT
END:VCALENDAR